Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions for Enhancing Sexual Responsiveness

a composition and composition technology, applied in the direction of biocide, plant/algae/fungi/lichens ingredients, peptide/protein ingredients, etc., can solve the problem that pharmaceutical agents are associated with adverse effects

Inactive Publication Date: 2007-08-30
BARMENSEN LABS
View PDF41 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a topical composition that contains various active ingredients such as methyl nicotinate, yohimbe, L-arginine, muira puama, catuaba, maca extract, saw palmetto, nettles, and zinc. The composition can be formulated in a topical lotion or a condom. The technical effect of the invention is to provide a topical composition that can help improve sexual performance and enhance sexual experience."

Problems solved by technology

Unfortunately, many or all of these pharmacological agents are associated with adverse effects including aggravation or induction of schizophrenia, serotonin syndrome, central nervous system and endocrine system dysfunction, pain, echytomosis and priapism.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0029] A preferred embodiment of the topical compositions of the present invention consists essentially of the following ingredients of a quality and purity suitable for topical application to a mammal:

Active ingredientAmount per 30 g ± 10%methyl nicotinate0.3gyohimbe extract25dropsL-arginine240mgmuira puama extract12dropscatuaba bark extract12dropsmaca extract12dropssaw palmetto12drops

[0030] These active ingredients were formulated in a base for topical administration in a pharmaceutically-acceptable topical vehicle containing distilled water, aloe barbadensis leaf juice, helianthus annus (sunflower) seed oil, stearic acid, glycine soja (soybean) oil, cetyl alcohol NF, emulsifying wax, olea Europaea (olive) fruit oil, glycerin, palmitic acid, cymbopogan schoenanthus (lemongrass) oil, mentha piperita (peppermint) oil, tocopherol, denatured alcohol, methyl salicylate, aloe barbadensis leaf extract, camella sinensis (green tea) leaf extract, rosmarinus officinalis (rosemary) leaf ex...

example 2

[0031] A preferred embodiment of the topical compositions of the present invention consists essentially of the following ingredients of a quality and purity suitable for topical application to a mammal:

Active ingredientAmount per 30 g ± 10%methyl nicotinate0.3gL-arginine240mgmuira puama extract12dropscatuaba bark extract12dropsmaca extract12drops

[0032] These active ingredients were formulated in a base for topical administration in a pharmaceutically-acceptable topical vehicle containing distilled water, aloe barbadensis leaf juice, helianthus annus (sunflower) seed oil, stearic acid, glycine soja (soybean) oil, cetyl alcohol, emulsifying wax, olea europaea (olive) fruit oil, glycerin, palmitic acid, fragrance, tocopherol, denatured alcohol, methyl salicylate, aloe barbadensis leaf extract, camella sinensis (green tea) leaf extract, rosmarinus officinalis (rosemary) leaf extract, citrus grandis (grapefruit) seed extract, lecithin, sodium bicarbonate, ascorbyl palmitate, polysorbat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pressuresaaaaaaaaaa
resistanceaaaaaaaaaa
venous resistanceaaaaaaaaaa
Login to View More

Abstract

A topical composition which enhances sexual responsiveness of a mammal is disclosed. An effective dosage of a peripheral vasodilator, an absorption enhancer and, optionally, a vasoconstrictor and an alpha receptor blocker are combined with a pharmaceutically-acceptable topical vehicle to produce the composition. The compositions are applied topically to the penis or labia majora and minora pudenda to enhance erection or vasocongestion.

Description

CROSS REFERENCE TO RELATED APPLICATION [0001] This application is a continuation of U.S. patent application Ser. No. 10 / 775,574, filed Feb. 9, 2004, now U.S. Pat. No. 7,214,390, which claims priority under 35 U.S.C. §119(e) to U.S. Provisional Patent Application Ser. No. 60 / 445,624, filed Feb. 7, 2003. These patent applications are incorporated herein, in their entirety, by this reference.FIELD OF THE INVENTION [0002] The invention relates to a topically-administered compositions for the enhancement of sexual responsiveness in mammals. BACKGROUND OF THE INVENTION [0003] The male sexual response includes the filling of vascular channels that are empty in the flaccid penis, with blood at pressures approaching systemic levels. Erection occurs when the arteriolar and sinusoidal smooth muscles of the vessels within the corpora relax, thus lowering resistance in these channels and allowing arterial blood to surge into the penis. Exit of the arterial blood is simultaneously impeded by an i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K36/886A61K36/48A61K36/82A61K36/28A61K31/198A61K31/455A61K31/375A61K31/355A61KA61K31/4745A61K33/30A61K36/00A61K36/185A61K36/31A61K36/74A61K36/889
CPCA61K9/0034A61K31/198A61K47/46A61K47/44A61K31/455A61K31/4745A61K33/30A61K36/185A61K36/28A61K36/31A61K36/48A61K36/74A61K36/82A61K36/886A61K36/889A61K47/14A61K2300/00
Inventor BARONE, FRANK V. JR.JACOBSEN, CHRISTOPHERCHUMENKO, KIRILL
Owner BARMENSEN LABS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com